Molecular Genetics & Genomic MedicineGeneticsPeer-reviewed journal article
Detection of GBA missense mutations and other variants using the Oxford Nanopore MinION
Melissa Leija‐SalazariD, Fritz Joachim SedlazeckiD, Marco ToffoliiD, Stephen MulliniD, Katya Mokretar, Maria Athanasopoulou, Aimée DonaldiD, Reena SharmaiD, Derralynn A. HughesiD, Anthony H.V. SchapiraiD, Christos ProukakisiD
Abstract
PurposeMutations in GBA cause Gaucher disease when biallelic, and are strong risk factors for Parkinsons disease when heterozygous. GBA analysis is complicated by the nearby pseudogene. We aimed to design and validate a method for sequencing GBA on the Oxford Nanopore MinION.\n\nMethodsWe sequenced an 8.9 kb amplicon from DNA samples of 17 individuals, including patients with Parkinsons and Gaucher disease, on older and current (R9.4) flow cells. These included samples with known mutations, assessed in a blinded fashion on the R9.4 data. We used NanoOK for quality metrics, two different aligners (Graphmap and NGMLR), Nanopolish and Sniffles to call variants, and Whatshap for phasing.\n\nResultsWe detected all known mutations, including the common p.N409S (N370S) and p.L483P (L444P), and three rarer ones, at the correct zygosity, as well as intronic SNPs. In a sample with the complex RecNciI allele, we detected an additional coding mutation, and a 55-base pair deletion. We confirmed compound heterozygosity where relevant. False positives were easily identified.\n\nConclusionThe Oxford Nanopore MinION can detect missense mutations and an exonic deletion in this difficult gene, with the added advantage of phasing and intronic analysis. It can be used as an efficient diagnostic tool.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- approach: experimental assay
- Citations
- 87
- FWCI
- 8.40
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinsons disease cohort
Oscar E.E. Graham, Toni L. Pitcher, … Martin Alexander Kennedy·Parkinsonism & Related DisordersPeer-reviewed·Nov 29, 2019
- GBA in Parkinson's disease: variant detection and pathogenicity scoring matters
Carolin Gabbert, Susen Schaake, … Joanne Trinh·medRxiv·Feb 3, 2023
- Comprehensive analysis of GBA using a novel algorithm for Illumina whole-genome sequence data or targeted Nanopore sequencing
Marco Toffoli, Xiao Chen, … Christos Proukakis·Communications BiologyPeer-reviewed·Jul 6, 2022
- Is Gauchian genotyping of GBA1 variants reliable?
Nahid Tayebi, Jens Lichtenberg, … Ellen Sidransky·Communications BiologyPeer-reviewed·May 9, 2025
- Accurate long-read sequencing identified GBA variants as a major genetic risk factor in the Luxembourg Parkinson's study
Sinthuja Pachchek, Zied Landoulsi, … Rejko Krüger·medRxiv·Mar 29, 2023
- Classification of GBA1 variants in Parkinson disease; the GBA1-PD browser
Sitki Cem Parlar, Francis P. Grenn, … Ziv Gan‐Or·Movement DisordersPeer-reviewed·Jan 4, 2023